A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across ...

Two new studies on NEFECON® demonstrate its treatment benefit in the 'Treat Early' strategy for IgA nephropathy (IgAN), providing robust support for the new disease management strategy: 'Treat the ...

Doctors in Jaipur removed a 210cm-long hairball from a 14-year-old girl, setting a new world record. The rare surgery was a ...

Study met its primary endpoints of safety, tolerability, and pharmacokinetics (PK) No serious adverse events (SAEs) or treatment-emergent adverse events (TEAEs) related to laboratory values or EKGs ...

PK analysis confirmed the delayed-release, terminal ileum-targeted and colon-targeted ... ratios confirmed localized drug activation in the distal gut with low systemic exposure.

Plasma-to-tissue ratios confirmed localized drug activation in the distal gut with low systemic exposure. Cmax and AUC increased roughly proportionally with dose; food intake modestly delayed Tmax and ...